首頁 > 市場調查報告書 > 製藥

泌尿科

市場調查報告書

商品編碼

2075300

尿道狹窄治療市場：按類型、治療方法、適應症、最終用戶和地區分類。

Urethral Stricture Treatment Market, By Type, By Treatment, By Disease Indication, By End User, By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，尿道狹窄治療市場規模將達到 19.884 億美元，到 2033 年將達到 30.697 億美元。預計從 2026 年到 2033 年，該市場將以 6.4% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1,988,400,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.40%	2033年市場規模預測：	30.697億美元

尿道狹窄是指因感染疾病或外傷引起的疤痕導致尿道內徑變窄的疾病。尿道狹窄分為兩種：後尿道狹窄和前尿道狹窄。後尿道狹窄是由於後尿道纖維化或外傷或骨盆骨折引起的牽拉傷所致。前尿道狹窄是最常見的狹窄類型，由感染或外傷引起的海綿體纖維化所致。此疾病可透過多種治療方案進行治療，包括直接體外內視鏡尿道切開術（DVIU）、尿道成形術和其他療法。尿道狹窄的主要症狀包括排尿困難、排尿刺激感、排尿時間延長、膀胱排空不盡感。已開發國家男性尿道狹窄的盛行率估計為0.9%。這種情況會導致尿路阻塞和刺激症狀，最終損害腎功能。尿道狹窄可能是泌尿系統診斷和治療手術引起的。隨著人口老化，這些操作越來越頻繁，因此，預計未來尿道狹窄的發生率將進一步增加。

市場動態

為了拓展產品系列，各公司正擴大採用非內部成長策略，例如獲得市場監管部門的批准，預計這將推動預測期內的市場成長。例如，2022年1月，為泌尿系統、婦科及其他領域提供產品的醫療技術公司Laborie宣布，其藥物塗層尿道球囊（DCB）「Optilume」已獲得美國食品藥物管理局（FDA）的許可。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球尿道狹窄治療市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
全球尿道狹窄治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球尿道狹窄治療市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Becton, Dickinson and Company
Amecath
Zhejiang Chuangxiang Medical Technology Co., Ltd
Allium Ltd.
SURGIMEDIK
Cook Group
Teawoong Medical Co., Ltd.
Teleflex Incorporated
B. Braun Melsungen AG
Coloplast A/S
Boston Scientific Corporation
Pnn Medical A/S
Laborie.

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI2381

Urethral Stricture Treatment Market is estimated to be valued at USD 1,988.4 Mn in 2026 and is expected to reach USD 3,069.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,988.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.40%	2033 Value Projection:	USD 3,069.7 Mn

Urethral stricture is the narrowing of the calibre of the urethra that is caused due to scarring resulting from infection or injury. There are two types of urethral strictures named posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries that result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures, and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral direct vision internal urethrotomy (DVIU), urethroplasty, and other treatments. The main symptoms of urethral stricture are obstructed and irritated micturition, with increased urination time, and a feeling of incomplete bladder emptying. Its prevalence among men in industrial countries is estimated at 0.9%. It produces obstructive and irritative urinary symptoms, and can ultimately impair renal function. Urethral strictures can be caused by diagnostic or therapeutic urological procedures. These procedures are being performed more commonly, because the population is aging, and thus, urethral strictures will probably become more common as well.

Market Dynamics

Increasing adoption of inorganic growth strategies such as approvals by the regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, Laborie., a medical technology company thath provide products for urology, gynecology, and others, announced that it has received a license to the Optilume, a urethral drug coated balloon (DCB), laborite., and product is approved from U.S. Food and Drug Administration (FDA).

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global urethral stricture treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S. , and Laborie.Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global urethral stricture treatrment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urethral stricture treatment market

Detailed Segmentation:

Global Urethral Stricture Treatment Market, By Type (Revenue, USD Mn, 2021 - 2033)
Posterior Urethral Stricture
Anterior Urethral Stricture
Global Urethral Stricture Treatment Market, By Treatment (Revenue, USD Mn, 2021 - 2033)
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
- Anastomotic Urethroplasty
- Substitution Urethroplasty
Others
Global Urethral Stricture Treatment Market, By Disease Indication:
Latrogenic
Idiopathic
Infection-induced
Trauma
Others
Global Urethral Stricture Treatment Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Others
Global Urethral Stricture Treatment Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Becton, Dickinson and Company*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Amecath
Zhejiang Chuangxiang
Medical Technology Co., Ltd
Koninklijke Philips N.V.
Allium Ltd.
SURGIMEDIK
Cook Group
Taewoong Medical Co., Ltd.
Teleflex Incorporated
Braun Melsungen AG
Coloplast A/S
Boston Scientific Corporation
Pnn Medical A/S

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment
- Market Snapshot, By Disease Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launches
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions

4. Global Urethral Stricture Treatment Market, By Type, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Posterior Urethral Stricture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Anterior Urethral Stricture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Urethral Stricture Treatment Market, By Treatment, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Urethral Dilation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Direct Vision Internal Urethrotomy (DVIU)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Urethroplasty
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  - Anastomotic Urethroplasty
  - Substitution Urethroplasty
Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)

6. Global Urethral Stricture Treatment Market, By Disease Indication, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Latrogenic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Idiopathic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Infection-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Trauma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)

7. Global Urethral Stricture Treatment Market, By End User, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-O-Y Growth analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)

8. Global Urethral Stricture Treatment Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amecath
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhejiang Chuangxiang Medical Technology Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Allium Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SURGIMEDIK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cook Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teawoong Medical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Coloplast A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pnn Medical A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Laborie.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球血尿治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

尿道狹窄治療市場規模、佔有率和成長分析：按治療類型、狹窄類型、手術類型、應用、最終用戶、患者群體和地區分類－2026-2033年產業預測

血尿治療市場規模、佔有率和趨勢分析報告：按治療類型、類型、地區和細分市場預測（2025-2033 年）

FAQ

尿道狹窄治療市場：按類型、治療方法、適應症、最終用戶和地區分類。